Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Robert A. Bradway has been appointed president and chief operating officer of Amgen, effective May 11.
April 27, 2010
By: Tim Wright
Robert A. Bradway has been appointed president and chief operating officer of Amgen, effective May 11. Mr. Bradway will be responsible for the company’s Global Commercial Operations, Manufacturing Operations, Strategy and Corporate Development, Information Technology, Global Government Affairs and Compliance. He will report to Kevin Sharer, Amgen’s chairman and chief executive officer. Mr. Bradway has served as the company’s executive vice president and chief financial officer since April 2007. He joined the company in 2006 as vice president, Operations Strategy. Prior to joining the company, he was a managing director at Morgan Stanley in London, where he was responsible for the firm’s banking department and corporate finance activities in Europe. Also, George J. Morrow, executive vice president of Global Commercial Operations, will retire effective January 31, 2011. Mr. Morrow will report to Mr. Sharer until his retirement and will be involved in the preparations for the company’s launch of Prolia (denosumab) as well as other strategic projects. “Bob Bradway is an outstanding executive with significant potential. He earned it,” Mr. Sharer said.”We note with deep appreciation and respect the exceptional accomplishment and contribution of George Morrow to the success of Amgen during the last decade. George will be focused on the success of Prolia worldwide for the balance of the year and will work with Bob and I on strategic initiatives and public policy. The new commercial leadership team that will report to Bob and take over day-to-day responsibility from George is seasoned and ready.” Also effective May 11, Michael A. Kelly, Amgen’s vice president of finance and chief accounting officer, will serve as acting chief financial officer. Mr. Kelly joined Amgen in 2003 and has served as chief accounting officer since 2005. “Michael Kelly is an able and experienced financial executive who will be the interim CFO reporting to me as we conduct an external search for a permanent CFO,” Mr. Sharer noted.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !